Most bought healthcare stocks in Q2 2013
See which Healthcare stocks institutional investors increased the most in Q2 2013, measured as net growth in reported share positions from Q1 2013 into Q2 2013. Notable additions at the top of this list include BOSTON SCIENTIFIC CORP (BSX), PFIZER INC (PFE), MERCK & CO. INC. (MRK), SANOFI-ADR (SNY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BSX | BOSTON SCIENTIFIC CORP | 92,149,055 | $863.60M | 3 | 0 | 1 | 0 | 4 |
| PFE | PFIZER INC | 84,188,128 | $2.36B | 12 | 2 | 0 | 0 | 14 |
| MRK | MERCK & CO. INC. | 53,429,405 | $2.49B | 9 | 1 | 1 | 0 | 11 |
| SNY | SANOFI-ADR | 51,701,924 | $2.66B | 9 | 0 | 0 | 0 | 9 |
| NVS | NOVARTIS AG-SPONSORED ADR | 51,302,975 | $3.63B | 8 | 0 | 0 | 0 | 8 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | 35,746,521 | $971.95M | 3 | 0 | 0 | 0 | 3 |
| JNJ | JOHNSON & JOHNSON | 28,519,030 | $2.28B | 18 | 3 | 0 | 0 | 21 |
| ABT | ABBOTT LABORATORIES | 25,136,561 | $876.51M | 7 | 1 | 0 | 0 | 8 |
| TMO | THERMO FISHER SCIENTIFIC INC | 22,601,528 | $1.91B | 9 | 0 | 0 | 0 | 9 |
| DVA | DAVITA INC | 15,681,856 | $1.89B | 2 | 0 | 0 | 0 | 2 |
| UNH | UNITEDHEALTH GROUP INC | 14,629,011 | $960.66M | 7 | 0 | 0 | 0 | 7 |
| SYK | STRYKER CORP | 14,370,626 | $808.46M | 4 | 1 | 0 | 0 | 5 |
| LLY | ELI LILLY & CO | 12,644,288 | $620.73M | 3 | 0 | 1 | 0 | 4 |
| DHR | DANAHER CORP | 12,295,875 | $778.33M | 3 | 0 | 0 | 0 | 3 |
| BMY | BRISTOL-MYERS SQUIBB CO | 9,060,330 | $404.97M | 5 | 1 | 0 | 0 | 6 |
| PDCO | PATTERSON COS INC | 8,378,203 | $315.02M | 4 | 0 | 0 | 0 | 4 |
| BAX | BAXTER INTERNATIONAL INC | 8,303,180 | $575.16M | 8 | 0 | 0 | 0 | 8 |
| BDX | BECTON DICKINSON AND CO | 7,824,534 | $773.30M | 8 | 0 | 1 | 0 | 9 |
| A | AGILENT TECHNOLOGIES INC | 7,744,281 | $332.69M | 5 | 0 | 0 | 0 | 5 |
| RVTY | REVVITY INC | 6,409,072 | $208.29M | 4 | 0 | 0 | 0 | 4 |
| GILD | GILEAD SCIENCES INC | 5,903,734 | $362.33M | 9 | 0 | 0 | 0 | 9 |
| GRFS | GRIFOLS SA-ADR | 5,810,347 | $163.92M | 2 | 0 | 0 | 0 | 2 |
| CVS | CVS HEALTH CORP | 5,695,360 | $325.67M | 3 | 0 | 0 | 0 | 4 |
| CRL | CHARLES RIVER LABORATORIES | 4,094,759 | $168.01M | 3 | 0 | 0 | 0 | 3 |
| WAT | WATERS CORP | 3,912,639 | $337.13M | 2 | 1 | 0 | 0 | 3 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 3,780,506 | $253.14M | 1 | 0 | 0 | 0 | 1 |
| GERN | GERON CORP | 3,694,176 | $5.54M | 2 | 0 | 0 | 0 | 2 |
| MYGN | MYRIAD GENETICS INC | 3,535,794 | $95.01M | 3 | 0 | 0 | 0 | 3 |
| ISRG | INTUITIVE SURGICAL INC | 3,503,246 | $1.77B | 6 | 0 | 0 | 0 | 6 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 3,497,151 | $137.09M | 6 | 0 | 0 | 0 | 6 |
| MASI | MASIMO CORP | 3,494,671 | $74.09M | 2 | 0 | 0 | 0 | 2 |
| ZTS | ZOETIS INC | 3,490,574 | $107.82M | 4 | 0 | 0 | 0 | 4 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 3,425,700 | $162.04M | 1 | 0 | 0 | 0 | 1 |
| CAH | CARDINAL HEALTH INC | 3,239,137 | $153.25M | 3 | 1 | 0 | 0 | 4 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 2,796,858 | $433.43M | 2 | 0 | 0 | 0 | 2 |
| CORT | CORCEPT THERAPEUTICS INC | 2,536,866 | $4.39M | 1 | 0 | 0 | 0 | 1 |
| BIIB | BIOGEN INC | 2,380,779 | $527.80M | 4 | 0 | 0 | 0 | 4 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 2,343,674 | $175.63M | 8 | 0 | 0 | 0 | 8 |
| TFX | TELEFLEX INC | 2,299,068 | $178.16M | 4 | 0 | 0 | 0 | 4 |
| MOH | MOLINA HEALTHCARE INC | 2,051,400 | $76.27M | 1 | 0 | 0 | 0 | 1 |
| HCA | HCA HEALTHCARE INC | 2,034,739 | $73.37M | 2 | 0 | 0 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | 1,931,066 | $51.06M | 2 | 0 | 0 | 0 | 2 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 1,754,300 | $82.24M | 2 | 0 | 0 | 0 | 2 |
| CPIX | CUMBERLAND PHARMACEUTICALS | 1,676,573 | $8.57M | 2 | 0 | 0 | 0 | 2 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | 1,592,438 | $8.22M | 2 | 0 | 0 | 0 | 2 |
| HOLX | HOLOGIC INC | 1,576,870 | $30.43M | 3 | 0 | 0 | 0 | 3 |
| AMGN | AMGEN INC | 1,556,641 | $153.68M | 4 | 0 | 0 | 0 | 4 |
| EW | EDWARDS LIFESCIENCES CORP | 1,528,349 | $102.70M | 2 | 0 | 0 | 0 | 2 |
| SRDX | SURMODICS INC | 1,371,330 | $27.44M | 3 | 0 | 0 | 0 | 3 |
| PETS | PETMED EXPRESS INC | 1,354,115 | $17.06M | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2013
What are the most bought Healthcare stocks in Q2 2013?
The most bought healthcare stocks in Q2 2013 are those with the largest increase in reported share counts across institutional investors compared to Q1 2013, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2013?
Among filers in this sector, net additions were largest in companies such as BOSTON SCIENTIFIC CORP (BSX), PFIZER INC (PFE), MERCK & CO. INC. (MRK), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2013).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.